These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8592689)

  • 1. Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys.
    Singh M; Singh O; Talwar GP
    Pharm Res; 1995 Nov; 12(11):1796-800. PubMed ID: 8592689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
    Talwar GP; Singh O; Singh V; Rao DN; Sharma NC; Das C; Rao LV
    Fertil Steril; 1986 Jul; 46(1):120-6. PubMed ID: 2424791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
    Rosas JE; Pedraz JL; Hernández RM; Gascón AR; Igartua M; Guzmán F; Rodríguez R; Cortés J; Patarroyo ME
    Vaccine; 2002 Mar; 20(13-14):1707-10. PubMed ID: 11906756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.
    Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL
    Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum.
    Diwan M; Dawar H; Talwar GP
    Prostate; 1998 Jun; 35(4):279-84. PubMed ID: 9609551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.
    Okada H; Doken Y; Ogawa Y; Toguchi H
    Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a novel approach to prepare biodegradable polylactic-co-glycolic acid microspheres: surface liquid spraying.
    Tang H; Xu N; Meng J; Wang C; Nie SF; Pan WS
    Yakugaku Zasshi; 2007 Nov; 127(11):1851-62. PubMed ID: 17978561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.
    Cui C; Stevens VC; Schwendeman SP
    Vaccine; 2007 Jan; 25(3):500-9. PubMed ID: 16996662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
    Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
    Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.
    Johansen P; Men Y; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2000 Jul; 50(1):129-46. PubMed ID: 10840197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.